Sandbox: malabsorption: Difference between revisions

VisualWikitext

Latest revision as of 16:37, 21 December 2017

Differential Diagnosis of Diarrhea

To review the differential diagnosis of diarrhea, click here.

To review the differential diagnosis of acute diarrhea, click here.

To review the differential diagnosis of chronic diarrhea, click here.

To review the differential diagnosis of traveler's diarrhea, click here.

To review the differential diagnosis of acute watery diarrhea, click here.

To review the differential diagnosis of acute bloody diarrhea, click here.

To review the differential diagnosis of acute fatty diarrhea, click here.

To review the differential diagnosis of chronic watery diarrhea, click here.

To review the differential diagnosis of chronic bloody diarrhea, click here.

To review the differential diagnosis of chronic fatty diarrhea, click here.

To review the differential diagnosis of acute diarrhea and fever, click here.

To review the differential diagnosis of chronic diarrhea and fever, click here.

To review the differential diagnosis of acute diarrhea and abdominal pain, click here.

To review the differential diagnosis of chronic diarrhea and abdominal pain, click here.

To review the differential diagnosis of acute diarrhea and weight loss, click here.

To review the differential diagnosis of chronic diarrhea and weight loss, click here.

Diarrhea

The following table outlines the major differential diagnoses of diarrhea.^[1]^[2]^[3]^[4]^[5]^[6]^[7]^[8]^[9]^[10]^[11]^[12]^[13]^[14]^[15]^[16]^[17]^[18]^[19]^[20]^[21]^[22]^[23]^[24]^[25]^[26]^[27]^[28]^[29]^[30]

Abbreviations: GI: Gastrointestinal, CBC: Complete blood count, WBC: White blood cell, RBC: Red blood cell, Plt: Platelet, Hgb: Hemoglobin, ESR: Erythrocyte sedimentation rate, CRP: C–reactive protein, IgE: Immunoglobulin E, IgA: Immunoglobulin A, ETEC: Escherichia coli enteritis, EPEC: Enteropathogenic Escherichia coli, EIEC: Enteroinvasive Escherichia coli, EHEC: Enterohemorrhagic Escherichia coli, EAEC: Enteroaggregative Escherichia coli, Nl: Normal, ASCA: Anti saccharomyces cerevisiae antibodies, ANCA: Anti–neutrophil cytoplasmic antibody, DNA: Deoxyribonucleic acid, CFTR: Cystic fibrosis transmembrane conductance regulator, SLC10A2: Solute carrier family 10 member 2, SeHCAT: Selenium homocholic acid taurine or tauroselcholic acid, IEL: Intraepithelial lymphocytes, MRCP: Magnetic resonance cholangiopancreatography, ANA: Antinuclear antibodies, AMA: Anti-mitochondrial antibody, LDH: Lactate dehydrogenase, CPK: Creatine phosphokinase, PCR: Polymerase chain reaction, ELISA: Enzyme–linked immunosorbent assay, LT: Heat–labile enterotoxin, ST: Heat–stable enterotoxin, RT-PCR: Reverse–transcriptase polymerase chain reaction, CD4: Cluster of differentiation 4, HIV: Human immunodeficiency virus, RUQ: Right-upper quadrant, VIP: Vasoactive intestinal peptide, GI: Gastrointestinal, FAP: Familial adenomatous polyposis, HNPCC: Hereditary nonpolyposis colorectal cancer, MTP: Microsomal triglyceride transfer protein, Scl‑70: Anti–topoisomerase I, TSH: Thyroid-stimulating hormone, T4: Thyroxine, T3: Triiodothyronine, DTR: Deep tendon reflex, RNA: Ribonucleic acid

				Symptoms								GI signs
Categories		Cause		Clinical manifestation									Lab findings									Extra intestinal findings	Cause/Pathogenesis	Gold standard diagnosis
				Duration		Diarrhea			Fever	Abdominal pain	Weight loss
				Duration		Diarrhea							Stool exam					CBC			Other lab findings
				Acute	Chronic	Watery	Bloody	Fatty					WBC	RBC	Ova/Parasite	Osmotic gap	Other	WBC	Hgb	Plt	Other lab findings
Gastrointestinal		Crohn's disease		–	+	+	+	+	±	+	+	Abdominal tenderness Oral mucosal lesions	+	+	–	Nl	–	↑	↓	↑	Anti saccharomyces cerevisiae antibodies (ASCA) Vitamin B12 deficiency Elevated ESR Elevated CRP	Uveitis Arthritis Erythema nodosum Pyoderma gangrenosum Amyloidosis Venous and arterial thromboembolism Renal stones Bronchiectasis	Abnormal immune response to self antigens	Colonoscopy with biopsy
		Ulcerative colitis		–	+	+	+	+	±	+	+	Abdominal tenderness Blood on rectal examination	+	+	–	Nl	–	↑	↓	↑	Anti–neutrophil cytoplasmic antibody (P–ANCA) Hypoalbuminemia Hypokalemia Hypomagnesemia Elevated ESR Elevated CRP	Skin rash Iritis Uveitis Seronegative arthritis Clubbing Erythema nodosum	Abnormal immune response to self antigens	Colonoscopy with biopsy
		Celiac disease		–	+	±	–	±	–	+	+	Abdominal distention Increased bowel sounds Oral mucosal lesions Hepatosplenomegaly Ascites	–	–	–	Nl	Fat droplets on sudan stain	Nl	↓	Nl	IgA endomysial antibody Anti–tissue transglutaminase antibody Anti–gliadin antibody Fat soluble vitamins deficiency	Malabsorption Dementia Dermatitis herpetiformis	HLA–DQ2 HLA–DQ8 Innate responses to wheat proteins	IgA endomysial antibody Anti–tissue transglutaminase antibody
		Cystic fibrosis		–	+	–	–	+	±	+	+	Abdominal distention Hepatosplenomegaly Rectal prolapse	–	–	–	Nl	Fat droplets on sudan stain	Nl	↓	Nl	Positive DNA analysis for cystic fibrosis transmembrane conductance regulator (CFTR) Nasal transepithelial potential difference Fat soluble vitamins deficiency	Malabsorption Recurrent respiratory tract infection Bronchiectasis Diabetes mellitus Scoliosis Infertility	Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein	Positive genetic testing Elevated sweat chloride ≥60 mmol/L
		Chronic pancreatitis		–	+	+	–	+	–	+	+	Abdominal tenderness	–	–	–	Nl	Fat droplets on sudan stain Positive fecal elastase measurement	Nl	Nl	Nl	Slightly elevated amylase and lipase Abnormal pancreatic function test Secretin stimulation test	Malabsorption Diabetes mellitus Pancreatic pseudocyst	Toxins Recurrent acute pancreatitis Genetic predesposition Autoimmune	Magnetic resonance cholangiopancreatography (MRCP)
		Bile acid malabsorption		–	+	+	–	+	–	–	+		–	–	–	Nl	Fat droplets on sudan stain	Nl	Nl	Nl	Reduced cholesterol level	Malabsorption Hypotension Tachycardia	Genetic defects in SLC10A2	SeHCAT test
		Microscopic colitis		–	+	+	–	–	–	+	+	Abdominal tenderness Fecal incontinence	–	–	–	Nl	–	Nl	↓	Nl	Hypokalemia Elevated CRP Positive autoantibodies include: RF ANA AMA ANCA	Arthritis Uveitis Idiopathic thrombocytopenic purpura Pleuro pericarditis Hypothyroidism Psoriasis	Mucosal immune responses to luminal factors in a genetically predisposed individual Drug–induced	Colonoscopy with mucosal biopsy with mononuclear infiltrates: Collagenous colitis is characterized by a colonic subepithelial collagen band >10 micrometers in diameter Lymphocytic colitis is characterized by ≥20 intraepithelial lymphocytes (IEL) per 100 surface epithelial cells
		Infective colitis		–	+	+	+	–	+	+	+	Rebound abdominal tenderness	+	+	+	Nl	Positive stool culture Positive fecal calprotectin Positive fecal lactoferrin	↑	↓	↑	Elevated CRP Elevated ESR	Arthritis Uveitis	Salmonella Shigella Campylobacter E. coli 0157:H7 Clostridium difficile Entamoeba histolytica Adenovirus Cytomegalovirus Herpes simplex virus	Stool culture Blood culture
		Ischemic colitis		+	+	+	+	–	+	+	+	Hyperactive then absent bowel sounds Abdominal tenderness	+	+	–	Nl	–	↑	↓	↑	Elevated CRP Elevated ESR Elevated serum lactate Elevated lactate dehydrogenase (LDH) Elevated creatine phosphokinase (CPK) Elevated amylase Hypoalbuminemia	IgA vasculitis	Hypercoagulability Nonocclusive colonic ischemia Embolic and thrombotic arterial occlusion Mesenteric vein thrombosis	Abdominal CT scan
		Lactose intolerance		+	+	+	–	–	–	+	–	Abdominal tenderness Abdominal distention	–	–	–	↑	–	Nl	Nl	Nl	Lactose tolerance test Genetic testing	Headache Vertigo Memory impairment Lethargy	Reduction of lactase enzyme activity or inability to produce persistent lactase Congenital lactase deficiency Secondary lactose malabsorption	Small bowel biopsy Lactose breath hydrogen test
		Irritable bowel syndrome		–	+	±	–	±	–	±	–	Abdominal tenderness Abdominal distention Normal bowel sounds	–	–	–	Nl	–	Nl	Nl	Nl	Nl	Anxiety Palpitation	Unknown	Diagnosis of exclusion
Infection	Bacterial	Whipple's disease		–	+	+	–	+	±	+	+	Hepatosplenomegaly Ascites	–	–	–	Nl	Positive fecal fat	↓	↓	↓/↑	Hypoalbuminemia Fat soluble vitamins deficiency	Malabsorption Abnormal extraocular movement Lymphadenopathy Hyperpigmentation Uveitis Endocarditis Encephalitis Dementia Pleural effusion	Tropheryma whipplei	Small intestine biopsy for Tropheryma whipplei testing PCR testing
		Tropical sprue		+	+	+	–	+	+	+	+	Angular stomatitis Oral mucosal lesion	+	–	–	Nl	Positive stool culture	Nl	↓	Nl	Fat soluble vitamins deficiency Vitamin B12 deficiency Folate deficiency Hypokalemia	Myalgia Neuropathy Edema	Escherichia coli Klebsiella pneumoniae Enterobacter cloacae	Diagnosis of exclusion
		Small bowel bacterial overgrowth		–	+	+	–	+	–	+	+	Abdominal distention	+	–	–	Nl	Positive stool culture Positive fecal fat	Nl	↓	Nl	Hypoalbuminemia Abnormal hydrogen breath test Lactic acidosis	Malabsorption Rosacea	Excess bacteria in the small intestine Alterations in intestinal anatomy or GI motility	Diagnosis of exclusion
		Pseudomembranous enterocolitis		+	–	+	±	–	+	+	±	Generalized abdominal tenderness Abdominal distention Rebound abdominal tenderness	+	+	–	Nl	Enzyme–linked immunosorbent assay (ELISA) Polymerase chain reaction (PCR) assay or C. difficile antigen	↑	↓	↓	Elevated serum creatinine Hypoalbuminemia Elevated lactic acid	Dehydration Acute kidney injury Bacteremia Reactive arthritis Necrotizing fasciitis	Clostridium difficile Recent antibiotics use Recent surgery	Stool exam Pseudomembranes on colonoscopy
		Campylobacteriosis		+	–	+	+	–	+	+	–	Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑	Nl	Nl	Nl	Toxic megacolon Sepsis Arthritis Endocarditis Guillain–Barré syndrome	Campylobacter jejuni	Stool culture
		Salmonellosis		+	+	+	+	–	+	+	–	Abdominal distention Diffuse abdominal tenderness Hepatosplenomegaly	+	+	–	Nl	Positive stool culture Positive serologic testing	↑	Nl	↑	Hypokalemia Hypernatremia Hyponatremia Hypercalciuria Hypocitraturia	Post–infectious arthritis Obtundation Bacteremia Pericarditis Pyelonephritis Brain abscess	Salmonella	Stool culture
		Shigellosis		+	–	+	+	–	+	+	–	Abdominal distention Hyperactive bowel sounds Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑/↓	↓	↓	Elevated CRP Elevated ESR Hyponatremia Hypoglycemia Azotemia	Headache Lethargy Seizures Delirium Post–infectious arthritis Myocarditis	Shigella	Stool culture
		Escherichia coli enteritis	ETEC (Traveler's diarrhea)	+	–	+	–	–	+	–	–	Diffuse abdominal tenderness	+	–	–	Nl	Positive stool culture	↑	Nl	Nl	–	–	Enterotoxigenic escherichia coli Enterotoxins: Heat–labile enterotoxin (LT) Heat–stable enterotoxin (ST)	Stool culture
			EPEC	+	+	+	+	–	+	+	+	Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑	Nl	Nl	–	–	Enteropathogenic E. coli	DNA probe or polymerase chain reaction (PCR) of the EPEC adherence factor Stool culture
			EIEC	+	–	+	+	–	+	+	–	Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑	Nl	Nl	–	–	Enteroinvasive E. coli	DNA probe Stool culture
			EHEC	+	–	+	+	–	–	+	–	Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑	↓	↓	Azotemia	Hemolytic uremic syndrome (HUS) Renal failure	Enterohemorrhagic E. coli Shiga toxins	Stool culture
			EAEC	+	+	+	+	–	–	+	–	Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑	↓	↓	–	Chronic infection in immunocompromised patients	Enteroaggregative E. coli	Stool culture
		Yersinia enterocolitica		+	–	+	+	–	+	+	–	Abdominal distention Hyperactive bowel sounds Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑	Nl	Nl	–	Bacteremia Reactive arthritis Glomerulonephritis Endocarditis Erythema nodosum Abscess	Yersinia enterocolitica	Stool culture
		Vibrio cholera		+	–	+	–	–	–	+	–		+	–	–	Nl	Positive stool culture	↑	Nl	Nl	Azotemia	Severe dehydration Decreased skin turgor Oliguria Renal failure Muscle cramps Seizure Somnolence	Cholera toxin	Stool culture
		Aeromonas		+	+	+	+	–	+	+	–	Abdominal distention Hyperactive bowel sounds Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑	Nl	Nl	–	Wound infection Bacteremia Hemolytic uremic syndrome Meningitis Ocular infection Pneumonia Urinary tract infection Osteomyelitis Peritonitis Acute cholecystitis Opportunistic infections in immunocompromised patients	Aeromonas virulence factors including endotoxins, hemolysins, enterotoxins, and adherence factors	Blood culture Wound culture
		Plesiomonas		+	–	+	+	–	+	+	–	Hyperactive bowel sounds Diffuse abdominal tenderness	+	+	–	Nl	Positive stool culture	↑	Nl	Nl	–	Opportunistic infections in immunocompromised patients or hepatobiliary disease Bacteremia Cellulitis and skin abscesses Peritonitis Meningoencephalitis Ocular infection Pneumonia Prosthetic joint infection Septic abortion	Plesiomonas shigelloides	Blood culture
		Mycobacterium avium complex		+	+	+	+	–	+	+	–	Abdominal distention Hepatosplenomegaly	+	+	–	Nl	–	↓	↓	Nl	Elevated liver enzymes	Opportunistic infection in immunocompromised patients Pulmonary infection Adenopathy Night sweats	Mycobacterium avium complex	Blood culture
		Food poisoning Staphylococcus aureus Bacillus cereus Clostridium perfringens		+	–	+	±	–	+	+	±	Abdominal distention	+	±	–	Nl	Positive stool culture	↑	Nl	Nl	–	History of travel or ingestion of infected food	Enterotoxins	Stool culture
	Virus	Norovirus		+	–	+	–	–	+	+	–	Abdominal distention	–	–	–	Nl	Positive stool reverse–transcriptase polymerase chain reaction (RT–PCR)	↓	Nl	Nl	–	Myalgia Headache Seizure Encephalopathy	Norovirus	Clinical diagnosis
		Rotavirus		+	–	+	–	–	+	–	–	Hyperactive bowel sounds Diffuse abdominal tenderness	+	–	–	Nl	–	Nl	Nl	Nl	Elevated blood urea nitrogen Hyperchloremic acidosis Hypocalcemia	Necrotizing enterocolitis Intussusception Biliary atresia Central nervous system involvement	Rotavirus	Stool immune–based assays
		Echovirus		+	–	+	–	–	+	+	–	Abdominal distention	–	–	–	Nl	–	Nl	Nl	Nl	–	Liver failure Myocarditis	Echovirus	Clinical diagnosis
		Adenovirus		+	–	+	–	–	+	+	–	Abdominal distention	–	–	–	Nl	Viral antigen assay	Nl	Nl	Nl	–	Respiratory disease Follicular conjunctivitis Epidemic keratoconjunctivitis Hepatitis Urethritis Myocarditis Meningitis Bacteremia	Adenovirus	Clinical diagnosis
		CMV colitis		+	+	–	+	–	±	+	–	Diffuse abdominal tenderness	+	+	–	Nl	Viral antigen assay	↓	Nl	Nl	Decreased CD4 level Abnormal liver function test	Encephalitis Guillain–Barré syndrome Pneumonia Retinitis Pericarditis and myocarditis Atherosclerosis Venous thrombosis	Cytomegalovirus	Quantitative PCR tests
		HIV		–	+	+	–	–	+	+	+	Abdominal distention Diffuse abdominal tenderness	+	–	–	Nl	–	↓	↓	Nl	Decreased CD4 level Electrolyte imbalance	Lymphadenopathy Disseminated infection	HIV	HIV virologic (viral load) test Immunoassay
	Parasite	Entamoeba histolytica		+	+	+	+	–	+	+	–	Abdominal distention Diffuse abdominal tenderness	+	+	+	Nl	–	↑	Nl	Nl	–	Liver abscess Pleuropulmonary infection Cardiac infection Brain abscess Cutaneous infection	Entamoeba histolytica	Antigen testing Serology
		Giardia		–	+	+	–	+	–	+	+	Abdominal distention Diffuse abdominal tenderness	–	–	+	Nl	–	Nl	Nl	Nl	–	Malabsorption Urticaria Depression	Giardia lamblia	Antigen detection assays
		Cryptosporidium		–	+	+	–	–	–	+	+	Abdominal distention Diffuse abdominal tenderness	–	–	+	Nl	Positive stool microscopy	Nl	Nl	Nl	Elevated alkaline phosphatase	Chronic, life–threatening illness in immunocompromised patients	Cryptosporidium	Polymerase chain reaction
		Microsporidia		+	+	+	–	–	+	+	–	Abdominal distention Diffuse abdominal tenderness	–	–	+	Nl	Positive stool microscopy	Nl	Nl	Nl	Decreased CD4 count	Malabsorption Keratitis Seizure Myositis	Microsporidia	Antigen detection assays
		Isospora		+	+	+	–	+	+	+	+	Abdominal distention Diffuse abdominal tenderness	+	+	+	Nl	Positive stool microscopy Positive fecal fat	↑	Nl	Nl	Elevated eosinophils Hypokalemia Increased creatinine	Chronic illness in immunocompromised patients	Isospora	Detecting oocysts in the feces
Tumors		Carcinoid tumor		–	+	+	+	–	–	+	+	Abdominal distention	–	+	–	↓	–	Nl	Nl	Nl	Elevated urinary 5–hydroxyindoleacetic acid (5–HIAA) level High chromogranin A	Facial flushing Jaundice Edema Valvular heart disease Right–sided heart failure	Well–differentiated neuroendocrine tumor	Blood chromogranin A level
		VIPoma		+	+	+	–	+	–	+	+	Abdominal distention Abdominal RUQ tenderness Nausea Vomiting	–	–	–	↓	–	Nl	Nl	Nl	Elevated VIP level Hypokalemia Hypochlorhydria or achlorhydria Low osmotic gap (<50 mOsm/kg)	Rash Facial flushing Dehydration Lethargy Muscle weakness	Primary secretory tumor	Blood VIP levels Followed by imaging
		Zollinger–Ellison syndrome		–	+	+	+	+	–	+	+	Epigastric tenderness	–	–	–	↓	–	Nl	↓	Nl	Positive secretin stimulation test Elevated serum chromogranin A	Jaundice	Gastrin producing tumor mainly in duodenum	Secretin stimulation test
		Somatostatinoma		–	+	+	–	–	–	+	+	Epigastric tenderness	–	–	–	↓	–	Nl	Nl	Nl	Elevated fasting plasma somatostatin	Diabetes mellitus Cholelithiasis Jaundice	Neuroendocrine tumors of D–cell origin	Plasma somatostatin level Followed by imaging
		Lymphoma		–	+	+	+	–	+	+	+	Diffuse abdominal tenderness Hepatosplenomegaly	–	+	–	Nl	–	Nl	↓	Nl	Paraproteinemia	Malabsorption Lactose intolerance Ascites	Primary tumor of GI tract	Colonoscopy with biopsy
		Colorectal cancer		–	+	+	+	+	–	+	+	Diffuse abdominal tenderness	–	+	–	Nl	–	Nl	↓	Nl	Positive carcinoembryonic antigen	Metastasis	FAP gene HNPCC gene	Colonoscopy and biopsy
Medication/Toxicity		Medications ACE inhibitors Digoxin Cephalosporins Statins Thiazide diuretics Triptans Lactulose Anti retroviral agents Chemotherapeutic agents Antifungals Magnesium		+	+	+	–	±	±	+	+	Abdominal distention Dehydration	–	–	–	↑/↓	–	↑	Nl	Nl	Elevated plasma level of drug	–	Inflammation Pseudomembranous colitis	Clinical evaluation after discontinuation of the drugs
		Factitious diarrhea		+	+	+	–	–	–	+	+	Abdominal distention	–	–	–	↑/↓	–	Nl	Nl	Nl	Hypokalemia Metabolic alkalosis Hypermagnesemia	Malabsorption Lethargy Generalized weakness Acute renal failure	Medications	Clinical evaluation after discontinuation of the drugs
		Heavy metal ingestion		–	+	+	–	–	–	+	+	Abdominal distention	–	–	–	Nl	–	Nl	Nl	Nl	Elevated plasma heavy metal level	Headache Numbness Alopecia Vertigo	Heavy metal ingestion	Plasma level of heavy metal
		Organophosphate poisoning		+	+	+	–	–	–	+	–	Salivation Vomiting	–	–	–	Nl	–	Nl	Nl	Nl	Reduced RBC acetylcholinesterase Plasma cholinesterase activity	Autonomic dysfunction Motor deficit Sensory deficit Bronchospasm Urination Miosis Bradycardia Lacrimation Sweating Cardiac arrhythmias Acute renal injury	Neurotoxins bind to acetylcholinesterase (AChE)	Clinical diagnosis
		Opium withdrawal		+	+	+	–	–	–	+	–	Hyperactive bowel sounds	–	–	–	Nl	–	Nl	Nl	Nl	Azotemia Hypokalemia Metabolic alkalosis	Dysphoria Restlessness Sweating Rhinorrhea Lacrimation Myalgia Arthralgia	Opium withdrawal	Clinical diagnosis following opium withdrawal
Iatrogenic		Short bowel syndrome		+	+	+	–	+	–	–	+	Abdominal distention Abdominal tenderness	–	–	–	Nl	Positive fecal fat	Nl	↓	↑	Hypoalbuminemia High level of acute phase reactant Abnormal liver function tests	Prior intestinal surgery Malabsorption Crohn's disease Malignancy Peripheral edema Muscle atrophy	Surgical bowel resection	Clinical diagnosis following bowel resection
		Radiation enteritis		+	+	+	+	+	–	+	+	Abdominal tenderness	+	+	–	Nl	Positive fecal fat	Nl	↓	Nl	Vitamin B12 deficiency Hypoalbuminemia	Prior history of malignancy and radiation therapy Malabsorption Telangiectasias	Radiation	Segmental bowel inflammation on endoscopy or colonoscopy
		Dumping syndrome		–	+	+	–	+	–	–	+	Hyperactive bowel sound	–	–	–	Nl	–	Nl	Nl	Nl	Hypoglycemia Hydrogen breath test	Malnutrition Fat soluble vitamin deficiency	Postgastrectomy	Clinical diagnosis following gastrectomy
Others		Abetalipoproteinemia		–	+	+	–	+	–	+	+	Abdominal distension	–	–	–	Nl	–	Nl	Nl	Nl	Low triglyceride Low total cholesterol levels Acanthocytes Low vitamin E levels	Ataxia Visual field defect Dysarthria	Autosomal recessive disorder caused by mutations encoding the microsomal triglyceride transfer protein (MTP)	Clinical findings and low triglyceride and cholesterol level
		Hyperthyroidism		–	+	+	–	–	±	+	+	–	–	–	–	Nl	Positive fecal fat	Nl	Nl	Nl	Elevated T4 Elevated T3 Decreased TSH High serum alkaline phosphatase	Lump in the neck Lid lag Malabsorption Sweating Hyperpigmentation Proptosis Tremor Increased DTR	Graves' disease Hashimoto's thyroiditis Toxic adenoma	TSH
		Diabetic neuropathy		–	+	+	–	+	–	+	+	Fecal incontinence	–	–	–	Nl	Positive fecal fat	Nl	↓	Nl	Hyperglycemia Azotemia Hypokalemia	Malabsorption	Unclear Disordered motility Increased intestinal secretion Small intestinal bacterial overgrowth	Clinical diagnosis in a patient with long lasting diabetes mellitus
		Systemic sclerosis		–	+	+	±	+	–	+	+	Epigastric tenderness Fecal incontinence	–	+	–	Nl	Positive fecal fat	Nl	↓	Nl	Anti–topoisomerase I (Scl‑70) antibodies Antinuclear antibodies (ANA) Anti–centromere antibodies Anti–RNA polymerase III antibody	Malabsorption Skin changes Raynaud phenomenon Pulmonary hypertension Arthritis Telangiectasia Chronic renal failure	Autoimmune reaction	Clinical diagnosis Followed by serologic tests

↑ Casburn-Jones, Anna C; Farthing, Michael Jg (2004). "Traveler's diarrhea". Journal of Gastroenterology and Hepatology. 19 (6): 610–618. doi:10.1111/j.1440-1746.2003.03287.x. ISSN 0815-9319.
↑ Kamat, Deepak; Mathur, Ambika (2006). "Prevention and Management of Travelers' Diarrhea". Disease-a-Month. 52 (7): 289–302. doi:10.1016/j.disamonth.2006.08.003. ISSN 0011-5029.
↑ Pfeiffer, Margaret L.; DuPont, Herbert L.; Ochoa, Theresa J. (2012). "The patient presenting with acute dysentery – A systematic review". Journal of Infection. 64 (4): 374–386. doi:10.1016/j.jinf.2012.01.006. ISSN 0163-4453.
↑ Barr W, Smith A (2014). "Acute diarrhea". Am Fam Physician. 89 (3): 180–9. PMID 24506120.
↑ Amil Dias J (2017). "Celiac Disease: What Do We Know in 2017?". GE Port J Gastroenterol. 24 (6): 275–278. doi:10.1159/000479881. PMID 29255768.
↑ Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi A (2017). "Shigellosis". Lancet. doi:10.1016/S0140-6736(17)33296-8. PMID 29254859. Vancouver style error: initials (help)
↑ Yamamoto-Furusho, J.K.; Bosques-Padilla, F.; de-Paula, J.; Galiano, M.T.; Ibañez, P.; Juliao, F.; Kotze, P.G.; Rocha, J.L.; Steinwurz, F.; Veitia, G.; Zaltman, C. (2017). "Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation". Revista de Gastroenterología de México. 82 (1): 46–84. doi:10.1016/j.rgmx.2016.07.003. ISSN 0375-0906.
↑ Borbély, Yves M; Osterwalder, Alice; Kröll, Dino; Nett, Philipp C; Inglin, Roman A (2017). "Diarrhea after bariatric procedures: Diagnosis and therapy". World Journal of Gastroenterology. 23 (26): 4689. doi:10.3748/wjg.v23.i26.4689. ISSN 1007-9327.
↑ Crawford, Sue E.; Ramani, Sasirekha; Tate, Jacqueline E.; Parashar, Umesh D.; Svensson, Lennart; Hagbom, Marie; Franco, Manuel A.; Greenberg, Harry B.; O'Ryan, Miguel; Kang, Gagandeep; Desselberger, Ulrich; Estes, Mary K. (2017). "Rotavirus infection". Nature Reviews Disease Primers. 3: 17083. doi:10.1038/nrdp.2017.83. ISSN 2056-676X.
↑ Kist M (2000). "[Chronic diarrhea: value of microbiology in diagnosis]". Praxis (Bern 1994) (in German). 89 (39): 1559–65. PMID 11068510.
↑ Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH (1985). "Evaluation and diagnosis of acute infectious diarrhea". Am. J. Med. 78 (6B): 91–8. PMID 4014291.
↑ López-Vélez R, Turrientes MC, Garrón C, Montilla P, Navajas R, Fenoy S, del Aguila C (1999). "Microsporidiosis in travelers with diarrhea from the tropics". J Travel Med. 6 (4): 223–7. PMID 10575169.
↑ Wahnschaffe, Ulrich; Ignatius, Ralf; Loddenkemper, Christoph; Liesenfeld, Oliver; Muehlen, Marion; Jelinek, Thomas; Burchard, Gerd Dieter; Weinke, Thomas; Harms, Gundel; Stein, Harald; Zeitz, Martin; Ullrich, Reiner; Schneider, Thomas (2009). "Diagnostic value of endoscopy for the diagnosis of giardiasis and other intestinal diseases in patients with persistent diarrhea from tropical or subtropical areas". Scandinavian Journal of Gastroenterology. 42 (3): 391–396. doi:10.1080/00365520600881193. ISSN 0036-5521.
↑ Mena Bares LM, Carmona Asenjo E, García Sánchez MV, Moreno Ortega E, Maza Muret FR, Guiote Moreno MV, Santos Bueno AM, Iglesias Flores E, Benítez Cantero JM, Vallejo Casas JA (2017). "75SeHCAT scan in bile acid malabsorption in chronic diarrhoea". Rev Esp Med Nucl Imagen Mol. 36 (1): 37–47. doi:10.1016/j.remn.2016.08.005. PMID 27765536.
↑ Gibson RJ, Stringer AM (2009). "Chemotherapy-induced diarrhoea". Curr Opin Support Palliat Care. 3 (1): 31–5. doi:10.1097/SPC.0b013e32832531bb. PMID 19365159.
↑ Abraham BP, Sellin JH (2012). "Drug-induced, factitious, & idiopathic diarrhoea". Best Pract Res Clin Gastroenterol. 26 (5): 633–48. doi:10.1016/j.bpg.2012.11.007. PMID 23384808.
↑ Reintam Blaser A, Deane AM, Fruhwald S (2015). "Diarrhoea in the critically ill". Curr Opin Crit Care. 21 (2): 142–53. doi:10.1097/MCC.0000000000000188. PMID 25692805.
↑ McMahan ZH, DuPont HL (2007). "Review article: the history of acute infectious diarrhoea management--from poorly focused empiricism to fluid therapy and modern pharmacotherapy". Aliment. Pharmacol. Ther. 25 (7): 759–69. doi:10.1111/j.1365-2036.2007.03261.x. PMID 17373914.
↑ Schiller LR (2012). "Definitions, pathophysiology, and evaluation of chronic diarrhoea". Best Pract Res Clin Gastroenterol. 26 (5): 551–62. doi:10.1016/j.bpg.2012.11.011. PMID 23384801.
↑ Giannella RA (1986). "Chronic diarrhea in travelers: diagnostic and therapeutic considerations". Rev. Infect. Dis. 8 Suppl 2: S223–6. PMID 3523719.
↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
↑ Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
↑ Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
↑ RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
↑ Konvolinka CW (1994). "Acute diverticulitis under age forty". Am J Surg. 167 (6): 562–5. PMID 8209928.
↑ Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006). "The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications". Gut. 55 (6): 749–53. doi:10.1136/gut.2005.082909. PMC 1856208. PMID 16698746.
↑ Haque R, Huston CD, Hughes M, Houpt E, Petri WA (2003). "Amebiasis". N Engl J Med. 348 (16): 1565–73. doi:10.1056/NEJMra022710. PMID 12700377.
↑ Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
↑ Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
↑ BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.

[Casburn-JonesFarthing2004-1] Casburn-Jones, Anna C; Farthing, Michael Jg (2004). "Traveler's diarrhea". Journal of Gastroenterology and Hepatology. 19 (6): 610–618. doi:10.1111/j.1440-1746.2003.03287.x. ISSN 0815-9319.

[KamatMathur2006-2] Kamat, Deepak; Mathur, Ambika (2006). "Prevention and Management of Travelers' Diarrhea". Disease-a-Month. 52 (7): 289–302. doi:10.1016/j.disamonth.2006.08.003. ISSN 0011-5029.

[PfeifferDuPont2012-3] Pfeiffer, Margaret L.; DuPont, Herbert L.; Ochoa, Theresa J. (2012). "The patient presenting with acute dysentery – A systematic review". Journal of Infection. 64 (4): 374–386. doi:10.1016/j.jinf.2012.01.006. ISSN 0163-4453.

[pmid24506120-4] Barr W, Smith A (2014). "Acute diarrhea". Am Fam Physician. 89 (3): 180–9. PMID 24506120.

[pmid29255768-5] Amil Dias J (2017). "Celiac Disease: What Do We Know in 2017?". GE Port J Gastroenterol. 24 (6): 275–278. doi:10.1159/000479881. PMID 29255768.

[pmid29254859-6] Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi A (2017). "Shigellosis". Lancet. doi:10.1016/S0140-6736(17)33296-8. PMID 29254859. Vancouver style error: initials (help)

[Yamamoto-FurushoBosques-Padilla2017-7] Yamamoto-Furusho, J.K.; Bosques-Padilla, F.; de-Paula, J.; Galiano, M.T.; Ibañez, P.; Juliao, F.; Kotze, P.G.; Rocha, J.L.; Steinwurz, F.; Veitia, G.; Zaltman, C. (2017). "Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation". Revista de Gastroenterología de México. 82 (1): 46–84. doi:10.1016/j.rgmx.2016.07.003. ISSN 0375-0906.

[BorbélyOsterwalder2017-8] Borbély, Yves M; Osterwalder, Alice; Kröll, Dino; Nett, Philipp C; Inglin, Roman A (2017). "Diarrhea after bariatric procedures: Diagnosis and therapy". World Journal of Gastroenterology. 23 (26): 4689. doi:10.3748/wjg.v23.i26.4689. ISSN 1007-9327.

[CrawfordRamani2017-9] Crawford, Sue E.; Ramani, Sasirekha; Tate, Jacqueline E.; Parashar, Umesh D.; Svensson, Lennart; Hagbom, Marie; Franco, Manuel A.; Greenberg, Harry B.; O'Ryan, Miguel; Kang, Gagandeep; Desselberger, Ulrich; Estes, Mary K. (2017). "Rotavirus infection". Nature Reviews Disease Primers. 3: 17083. doi:10.1038/nrdp.2017.83. ISSN 2056-676X.

[pmid11068510-10] Kist M (2000). "[Chronic diarrhea: value of microbiology in diagnosis]". Praxis (Bern 1994) (in German). 89 (39): 1559–65. PMID 11068510.

[pmid4014291-11] Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH (1985). "Evaluation and diagnosis of acute infectious diarrhea". Am. J. Med. 78 (6B): 91–8. PMID 4014291.

[pmid10575169-12] López-Vélez R, Turrientes MC, Garrón C, Montilla P, Navajas R, Fenoy S, del Aguila C (1999). "Microsporidiosis in travelers with diarrhea from the tropics". J Travel Med. 6 (4): 223–7. PMID 10575169.

[WahnschaffeIgnatius2009-13] Wahnschaffe, Ulrich; Ignatius, Ralf; Loddenkemper, Christoph; Liesenfeld, Oliver; Muehlen, Marion; Jelinek, Thomas; Burchard, Gerd Dieter; Weinke, Thomas; Harms, Gundel; Stein, Harald; Zeitz, Martin; Ullrich, Reiner; Schneider, Thomas (2009). "Diagnostic value of endoscopy for the diagnosis of giardiasis and other intestinal diseases in patients with persistent diarrhea from tropical or subtropical areas". Scandinavian Journal of Gastroenterology. 42 (3): 391–396. doi:10.1080/00365520600881193. ISSN 0036-5521.

[pmid27765536-14] Mena Bares LM, Carmona Asenjo E, García Sánchez MV, Moreno Ortega E, Maza Muret FR, Guiote Moreno MV, Santos Bueno AM, Iglesias Flores E, Benítez Cantero JM, Vallejo Casas JA (2017). "75SeHCAT scan in bile acid malabsorption in chronic diarrhoea". Rev Esp Med Nucl Imagen Mol. 36 (1): 37–47. doi:10.1016/j.remn.2016.08.005. PMID 27765536.

[pmid19365159-15] Gibson RJ, Stringer AM (2009). "Chemotherapy-induced diarrhoea". Curr Opin Support Palliat Care. 3 (1): 31–5. doi:10.1097/SPC.0b013e32832531bb. PMID 19365159.

[pmid23384808-16] Abraham BP, Sellin JH (2012). "Drug-induced, factitious, & idiopathic diarrhoea". Best Pract Res Clin Gastroenterol. 26 (5): 633–48. doi:10.1016/j.bpg.2012.11.007. PMID 23384808.

[pmid25692805-17] Reintam Blaser A, Deane AM, Fruhwald S (2015). "Diarrhoea in the critically ill". Curr Opin Crit Care. 21 (2): 142–53. doi:10.1097/MCC.0000000000000188. PMID 25692805.

[pmid17373914-18] McMahan ZH, DuPont HL (2007). "Review article: the history of acute infectious diarrhoea management--from poorly focused empiricism to fluid therapy and modern pharmacotherapy". Aliment. Pharmacol. Ther. 25 (7): 759–69. doi:10.1111/j.1365-2036.2007.03261.x. PMID 17373914.

[pmid23384801-19] Schiller LR (2012). "Definitions, pathophysiology, and evaluation of chronic diarrhoea". Best Pract Res Clin Gastroenterol. 26 (5): 551–62. doi:10.1016/j.bpg.2012.11.011. PMID 23384801.

[pmid3523719-20] Giannella RA (1986). "Chronic diarrhea in travelers: diagnostic and therapeutic considerations". Rev. Infect. Dis. 8 Suppl 2: S223–6. PMID 3523719.

[pmid16151544-21] Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.

[pmid12135027-22] Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.

[pmid1702075-23] Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.

[pmid14439871-24] RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.

[pmid8209928-25] Konvolinka CW (1994). "Acute diverticulitis under age forty". Am J Surg. 167 (6): 562–5. PMID 8209928.

[pmid16698746-26] Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006). "The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications". Gut. 55 (6): 749–53. doi:10.1136/gut.2005.082909. PMC 1856208. PMID 16698746.

[pmid12700377-27] Haque R, Huston CD, Hughes M, Houpt E, Petri WA (2003). "Amebiasis". N Engl J Med. 348 (16): 1565–73. doi:10.1056/NEJMra022710. PMID 12700377.

[pmid8694025-28] Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.

[pmid9414969-29] Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.

[pmid15391722-30] BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

@@ Line 1: / Line 1: @@
 ==Differential Diagnosis of Diarrhea==
-To review the differential diagnosis of diarrhea, click here.
+'''''To review the differential diagnosis of diarrhea, click here.'''''
-To review the differential diagnosis of acute diarrhea, click here.
-To review the differential diagnosis of chronic diarrhea, click here.
-To review the differential diagnosis of acute diarrhea and fever, click here.
-To review the differential diagnosis of chronic diarrhea and fever, click here.
+'''''To review the differential diagnosis of acute diarrhea, click here.'''''
+'''''To review the differential diagnosis of chronic diarrhea, click here.'''''
+'''''To review the differential diagnosis of traveler's diarrhea, click here.'''''
+'''''To review the differential diagnosis of acute watery diarrhea, click here.'''''
+'''''To review the differential diagnosis of acute bloody diarrhea, click here.'''''
+'''''To review the differential diagnosis of acute fatty diarrhea, click here.'''''
+'''''To review the differential diagnosis of chronic watery diarrhea, click here.'''''
+'''''To review the differential diagnosis of chronic bloody diarrhea, click here.'''''
+'''''To review the differential diagnosis of chronic fatty diarrhea, click here.'''''
+'''''To review the differential diagnosis of acute diarrhea and fever, click here.'''''
+'''''To review the differential diagnosis of chronic diarrhea and fever, click here.'''''
+'''''To review the differential diagnosis of acute diarrhea and abdominal pain, click here.'''''
+'''''To review the differential diagnosis of chronic diarrhea and abdominal pain, click here.'''''
+'''''To review the differential diagnosis of acute diarrhea and weight loss, click here.'''''
+'''''To review the differential diagnosis of chronic diarrhea and weight loss, click here.'''''
 ===Diarrhea===
+'''The following table outlines the major differential diagnoses of diarrhea.'''<ref name="Casburn-JonesFarthing2004">{{cite journal|last1=Casburn-Jones|first1=Anna C|last2=Farthing|first2=Michael Jg|title=Traveler's diarrhea|journal=Journal of Gastroenterology and Hepatology|volume=19|issue=6|year=2004|pages=610–618|issn=0815-9319|doi=10.1111/j.1440-1746.2003.03287.x}}</ref><ref name="KamatMathur2006">{{cite journal|last1=Kamat|first1=Deepak|last2=Mathur|first2=Ambika|title=Prevention and Management of Travelers’ Diarrhea|journal=Disease-a-Month|volume=52|issue=7|year=2006|pages=289–302|issn=00115029|doi=10.1016/j.disamonth.2006.08.003}}</ref><ref name="PfeifferDuPont2012">{{cite journal|last1=Pfeiffer|first1=Margaret L.|last2=DuPont|first2=Herbert L.|last3=Ochoa|first3=Theresa J.|title=The patient presenting with acute dysentery – A systematic review|journal=Journal of Infection|volume=64|issue=4|year=2012|pages=374–386|issn=01634453|doi=10.1016/j.jinf.2012.01.006}}</ref><ref name="pmid24506120">{{cite journal |vauthors=Barr W, Smith A |title=Acute diarrhea |journal=Am Fam Physician |volume=89 |issue=3 |pages=180–9 |year=2014 |pmid=24506120 |doi= |url=}}</ref><ref name="pmid29255768">{{cite journal |vauthors=Amil Dias J |title=Celiac Disease: What Do We Know in 2017? |journal=GE Port J Gastroenterol |volume=24 |issue=6 |pages=275–278 |year=2017 |pmid=29255768 |doi=10.1159/000479881 |url=}}</ref><ref name="pmid29254859">{{cite journal |vauthors=Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AKM |title=Shigellosis |journal=Lancet |volume= |issue= |pages= |year=2017 |pmid=29254859 |doi=10.1016/S0140-6736(17)33296-8 |url=}}</ref><ref name="Yamamoto-FurushoBosques-Padilla2017">{{cite journal|last1=Yamamoto-Furusho|first1=J.K.|last2=Bosques-Padilla|first2=F.|last3=de-Paula|first3=J.|last4=Galiano|first4=M.T.|last5=Ibañez|first5=P.|last6=Juliao|first6=F.|last7=Kotze|first7=P.G.|last8=Rocha|first8=J.L.|last9=Steinwurz|first9=F.|last10=Veitia|first10=G.|last11=Zaltman|first11=C.|title=Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn's and Colitis Organisation|journal=Revista de Gastroenterología de México|volume=82|issue=1|year=2017|pages=46–84|issn=03750906|doi=10.1016/j.rgmx.2016.07.003}}</ref><ref name="BorbélyOsterwalder2017">{{cite journal|last1=Borbély|first1=Yves M|last2=Osterwalder|first2=Alice|last3=Kröll|first3=Dino|last4=Nett|first4=Philipp C|last5=Inglin|first5=Roman A|title=Diarrhea after bariatric procedures: Diagnosis and therapy|journal=World Journal of Gastroenterology|volume=23|issue=26|year=2017|pages=4689|issn=1007-9327|doi=10.3748/wjg.v23.i26.4689}}</ref><ref name="CrawfordRamani2017">{{cite journal|last1=Crawford|first1=Sue E.|last2=Ramani|first2=Sasirekha|last3=Tate|first3=Jacqueline E.|last4=Parashar|first4=Umesh D.|last5=Svensson|first5=Lennart|last6=Hagbom|first6=Marie|last7=Franco|first7=Manuel A.|last8=Greenberg|first8=Harry B.|last9=O'Ryan|first9=Miguel|last10=Kang|first10=Gagandeep|last11=Desselberger|first11=Ulrich|last12=Estes|first12=Mary K.|title=Rotavirus infection|journal=Nature Reviews Disease Primers|volume=3|year=2017|pages=17083|issn=2056-676X|doi=10.1038/nrdp.2017.83}}</ref><ref name="pmid11068510">{{cite journal |vauthors=Kist M |title=[Chronic diarrhea: value of microbiology in diagnosis] |language=German |journal=Praxis (Bern 1994) |volume=89 |issue=39 |pages=1559–65 |year=2000 |pmid=11068510 |doi= |url=}}</ref><ref name="pmid4014291">{{cite journal |vauthors=Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH |title=Evaluation and diagnosis of acute infectious diarrhea |journal=Am. J. Med. |volume=78 |issue=6B |pages=91–8 |year=1985 |pmid=4014291 |doi= |url=}}</ref><ref name="pmid10575169">{{cite journal |vauthors=López-Vélez R, Turrientes MC, Garrón C, Montilla P, Navajas R, Fenoy S, del Aguila C |title=Microsporidiosis in travelers with diarrhea from the tropics |journal=J Travel Med |volume=6 |issue=4 |pages=223–7 |year=1999 |pmid=10575169 |doi= |url=}}</ref><ref name="WahnschaffeIgnatius2009">{{cite journal|last1=Wahnschaffe|first1=Ulrich|last2=Ignatius|first2=Ralf|last3=Loddenkemper|first3=Christoph|last4=Liesenfeld|first4=Oliver|last5=Muehlen|first5=Marion|last6=Jelinek|first6=Thomas|last7=Burchard|first7=Gerd Dieter|last8=Weinke|first8=Thomas|last9=Harms|first9=Gundel|last10=Stein|first10=Harald|last11=Zeitz|first11=Martin|last12=Ullrich|first12=Reiner|last13=Schneider|first13=Thomas|title=Diagnostic value of endoscopy for the diagnosis of giardiasis and other intestinal diseases in patients with persistent diarrhea from tropical or subtropical areas|journal=Scandinavian Journal of Gastroenterology|volume=42|issue=3|year=2009|pages=391–396|issn=0036-5521|doi=10.1080/00365520600881193}}</ref><ref name="pmid27765536">{{cite journal |vauthors=Mena Bares LM, Carmona Asenjo E, García Sánchez MV, Moreno Ortega E, Maza Muret FR, Guiote Moreno MV, Santos Bueno AM, Iglesias Flores E, Benítez Cantero JM, Vallejo Casas JA |title=75SeHCAT scan in bile acid malabsorption in chronic diarrhoea |journal=Rev Esp Med Nucl Imagen Mol |volume=36 |issue=1 |pages=37–47 |year=2017 |pmid=27765536 |doi=10.1016/j.remn.2016.08.005 |url=}}</ref><ref name="pmid19365159">{{cite journal |vauthors=Gibson RJ, Stringer AM |title=Chemotherapy-induced diarrhoea |journal=Curr Opin Support Palliat Care |volume=3 |issue=1 |pages=31–5 |year=2009 |pmid=19365159 |doi=10.1097/SPC.0b013e32832531bb |url=}}</ref><ref name="pmid23384808">{{cite journal |vauthors=Abraham BP, Sellin JH |title=Drug-induced, factitious, & idiopathic diarrhoea |journal=Best Pract Res Clin Gastroenterol |volume=26 |issue=5 |pages=633–48 |year=2012 |pmid=23384808 |doi=10.1016/j.bpg.2012.11.007 |url=}}</ref><ref name="pmid25692805">{{cite journal |vauthors=Reintam Blaser A, Deane AM, Fruhwald S |title=Diarrhoea in the critically ill |journal=Curr Opin Crit Care |volume=21 |issue=2 |pages=142–53 |year=2015 |pmid=25692805 |doi=10.1097/MCC.0000000000000188 |url=}}</ref><ref name="pmid17373914">{{cite journal |vauthors=McMahan ZH, DuPont HL |title=Review article: the history of acute infectious diarrhoea management--from poorly focused empiricism to fluid therapy and modern pharmacotherapy |journal=Aliment. Pharmacol. Ther. |volume=25 |issue=7 |pages=759–69 |year=2007 |pmid=17373914 |doi=10.1111/j.1365-2036.2007.03261.x |url=}}</ref><ref name="pmid23384801">{{cite journal |vauthors=Schiller LR |title=Definitions, pathophysiology, and evaluation of chronic diarrhoea |journal=Best Pract Res Clin Gastroenterol |volume=26 |issue=5 |pages=551–62 |year=2012 |pmid=23384801 |doi=10.1016/j.bpg.2012.11.011 |url=}}</ref><ref name="pmid3523719">{{cite journal |vauthors=Giannella RA |title=Chronic diarrhea in travelers: diagnostic and therapeutic considerations |journal=Rev. Infect. Dis. |volume=8 Suppl 2 |issue= |pages=S223–6 |year=1986 |pmid=3523719 |doi= |url=}}</ref><ref name="pmid16151544">{{cite journal| author=Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR et al.| title=Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. | journal=Can J Gastroenterol | year= 2005 | volume= 19 Suppl A | issue=  | pages= 5A-36A | pmid=16151544 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16151544  }}</ref><ref name="pmid12135027">{{cite journal| author=Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D| title=Bowel habits and bile acid malabsorption in the months after cholecystectomy. | journal=Am J Gastroenterol | year= 2002 | volume= 97 | issue= 7 | pages= 1732-5 | pmid=12135027 | doi=10.1111/j.1572-0241.2002.05779.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12135027  }}</ref><ref name="pmid1702075">{{cite journal| author=Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R et al.| title=Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. | journal=Gastroenterology | year= 1991 | volume= 100 | issue= 2 | pages= 359-69 | pmid=1702075 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1702075  }}</ref><ref name="pmid14439871">{{cite journal| author=RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC| title=Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. | journal=Gastroenterology | year= 1960 | volume= 38 | issue=  | pages= 28-49 | pmid=14439871 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14439871  }}</ref><ref name="pmid8209928">{{cite journal| author=Konvolinka CW| title=Acute diverticulitis under age forty. | journal=Am J Surg | year= 1994 | volume= 167 | issue= 6 | pages= 562-5 | pmid=8209928 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8209928  }} </ref><ref name="pmid16698746">{{cite journal| author=Satsangi J, Silverberg MS, Vermeire S, Colombel JF| title=The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. | journal=Gut | year= 2006 | volume= 55 | issue= 6 | pages= 749-53 | pmid=16698746 | doi=10.1136/gut.2005.082909 | pmc=1856208 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16698746  }} </ref><ref name="pmid12700377">{{cite journal| author=Haque R, Huston CD, Hughes M, Houpt E, Petri WA| title=Amebiasis. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 16 | pages= 1565-73 | pmid=12700377 | doi=10.1056/NEJMra022710 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12700377  }} </ref><ref name="pmid8694025">{{cite journal| author=Hertzler SR, Savaiano DA| title=Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. | journal=Am J Clin Nutr | year= 1996 | volume= 64 | issue= 2 | pages= 232-6 | pmid=8694025 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8694025  }} </ref><ref name="pmid9414969">{{cite journal| author=Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC| title=Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect? | journal=Gut | year= 1997 | volume= 41 | issue= 5 | pages= 632-5 | pmid=9414969 | doi= | pmc=1891556 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9414969  }} </ref><ref name="pmid15391722">{{cite journal| author=BLACK-SCHAFFER B| title=The tinctoral demonstration of a glycoprotein in Whipple's disease. | journal=Proc Soc Exp Biol Med | year= 1949 | volume= 72 | issue= 1 | pages= 225-7 | pmid=15391722 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15391722  }} </ref>
-<span style="font-size:85%">'''Abbreviations:''' '''GI:''' [[Gastrointestinal tract|Gastrointestinal]], '''CBC''': [[Complete blood count]], '''WBC:''' [[White blood cells|White blood cell]], '''RBC''': [[Red blood cell]], '''Plt:''' [[Platelet]], '''Hgb:''' [[Hemoglobin]], '''ESR''': [[Erythrocyte sedimentation rate]], '''CRP''': [[C-reactive protein|C–reactive protein]], '''IgE:''' [[Immunoglobulin E]], '''IgA:''' [[Immunoglobulin A]], '''ETEC:''' [[Escherichia coli enteritis]], '''EPEC''': [[Escherichia coli|Enteropathogenic Escherichia coli]], '''EIEC''': [[Escherichia coli enteritis|Enteroinvasive Escherichia coli]], '''EHEC''': [[Escherichia coli|Enterohemorrhagic Escherichia coli]], '''EAEC''': [[Escherichia coli enteritis|Enteroaggregative Escherichia coli]],</span>
+<span style="font-size:85%">'''Abbreviations:''' '''GI:''' [[Gastrointestinal tract|Gastrointestinal]], '''CBC''': [[Complete blood count]], '''WBC:''' [[White blood cells|White blood cell]], '''RBC''': [[Red blood cell]], '''Plt:''' [[Platelet]], '''Hgb:''' [[Hemoglobin]], '''ESR''': [[Erythrocyte sedimentation rate]], '''CRP''': [[C-reactive protein|C–reactive protein]], '''IgE:''' [[Immunoglobulin E]], '''IgA:''' [[Immunoglobulin A]], '''ETEC:''' [[Escherichia coli enteritis]], '''EPEC''': [[Escherichia coli|Enteropathogenic Escherichia coli]], '''EIEC''': [[Escherichia coli enteritis|Enteroinvasive Escherichia coli]], '''EHEC''': [[Escherichia coli|Enterohemorrhagic Escherichia coli]], '''EAEC''': [[Escherichia coli enteritis|Enteroaggregative Escherichia coli]], '''Nl''': Normal, '''ASCA''': [[Anti saccharomyces cerevisiae antibodies]], '''ANCA''': [[Anti-neutrophil cytoplasmic antibody|Anti–neutrophil cytoplasmic antibody]], '''DNA''': [[DNA|Deoxyribonucleic acid]], '''CFTR''': [[Cystic fibrosis transmembrane conductance regulator]], '''SLC10A2''': [[SLC10A2|Solute carrier family 10 member 2]], '''SeHCAT''': [[SeHCAT|Selenium homocholic acid taurine or tauroselcholic acid]], '''IEL''': Intraepithelial [[Lymphocyte|lymphocytes]], '''MRCP''': [[Magnetic resonance cholangiopancreatography]], '''ANA''': [[Antinuclear antibodies]], '''AMA''': [[Anti-mitochondrial antibody]], '''LDH''': [[Lactate dehydrogenase]], '''CPK''': [[Creatine phosphokinase]], '''PCR''': [[Polymerase chain reaction]], '''ELISA''': [[Enzyme linked immunosorbent assay (ELISA)|Enzyme–linked immunosorbent assay]], '''LT''': Heat–labile [[enterotoxin]], ST: Heat–stable [[enterotoxin]], '''RT-PCR''': Reverse–transcriptase [[polymerase chain reaction]], '''CD4:''' [[CD4|Cluster of differentiation 4]], '''HIV''': [[Human Immunodeficiency Virus (HIV)|Human immunodeficiency virus]], '''RUQ''': [[RUQ|Right-upper quadrant]], '''VIP''': [[Vasoactive intestinal peptide]], '''GI:''' [[Gastrointestinal tract|Gastrointestinal]], '''FAP''': [[Familial adenomatous polyposis]], '''HNPCC''': [[Hereditary nonpolyposis colorectal cancer]], '''MTP''': [[Microsomal triglyceride transfer protein]], '''Scl‑70''': Anti–[[Type I topoisomerase|topoisomerase I]], '''TSH''': [[Thyroid-stimulating hormone]], '''T4''': [[Thyroxine]], '''T3''': [[Triiodothyronine]], '''DTR''': [[Deep tendon reflex]], '''RNA''': [[RNA|Ribonucleic acid]]</span>
 {| class="wikitable" style="border: 0px; font-size: 100%; margin: 3px;" align="center"
@@ Line 49: / Line 74: @@
 |-
 ! colspan="2" rowspan="11" style="background:#4479BA; color: #FFFFFF;" align="center" |Gastrointestinal
-! colspan="2" style="background:#DCDCDC;" align="center" |[[Crohns disease]]
+! colspan="2" style="background:#DCDCDC;" align="center" |[[Crohns disease|Crohn's disease]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
@@ Line 60: / Line 85: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[Abdominal tenderness]]
-* [[Oral ulcer|Mouth ulcer]]
+* Oral [[mucosal]] lesions
-* [[Tachycardia]]
-* [[Hypotension]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
@@ Line 96: / Line 119: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ±
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* Normal in mild cases
 * [[Abdominal tenderness]]
-* [[Tachycardia]]
-* [[Hypotension]]
-* [[Pallor]]
 * [[Blood]] on [[rectal examination]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
@@ Line 126: / Line 145: @@
 * [[Uveitis]]
 * Seronegative [[arthritis]]
-* [[Clubbing]] of the fingers
+* [[Clubbing]]
 * [[Erythema nodosum]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
@@ Line 145: / Line 164: @@
 * [[Abdominal distention]]
 * Increased [[bowel]] sounds
-* [[Mouth ulcers]]
+* Oral [[Mucous membrane|mucosal]] lesions
 * [[Hepatosplenomegaly]]
 * [[Ascites]]
@@ Line 151: / Line 170: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Fat droplets on [[sudan stain]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[IgA]] endomysial [[antibody]]
@@ Line 190: / Line 209: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Fat droplets on [[sudan stain]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Positive [[DNA]] analysis for [[CFTR|cystic fibrosis transmembrane conductance regulator]] [[CFTR|(CFTR)]]
@@ Line 227: / Line 246: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Fat droplets on [[sudan stain]]
 * Positive [[fecal elastase]] measurement
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Slightly elevated [[amylase]] and [[lipase]]
@@ Line 244: / Line 263: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[Toxin|Toxins]]
-* Repeated [[acute pancreatitis]]
+* Recurrent [[acute pancreatitis]]
-* [[Genetics|Genetic]]
+* [[Genetics|Genetic]] predesposition
 * [[Autoimmunity|Autoimmune]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
@@ Line 260: / Line 279: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*[[Hypotension]]
-*[[Tachycardia]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Fat droplets on [[sudan stain]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Reduced [[cholesterol]] level
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Malabsorption]]
+*[[Hypotension]]
+*[[Tachycardia]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Genetic defects in ''[[SLC10A2]]''
@@ Line 295: / Line 314: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[Hypokalemia]]
 * Elevated [[C-reactive protein|CRP]]
-* Elevated [[autoantibodies]] include:
+* Positive [[autoantibodies]] include:
-**[[RF]]
+**RF
 **[[ANA]]
 **[[Anti-mitochondrial antibody|AMA]]
@@ Line 337: / Line 356: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
@@ Line 355: / Line 374: @@
 *[[Shigella|''Shigella'']]
 *[[Campylobacter|''Campylobacter'']]
-*''E. coli 0157:H7''
+*''[[Escherichia coli|E. coli 0157:H7]]''
 *[[Clostridium difficile|''Clostridium difficile'']]
 *[[Entamoeba histolytica|''Entamoeba histolytica'']]
@@ Line 380: / Line 399: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
@@ Line 415: / Line 433: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[Abdominal tenderness ]]
-* [[Hypotension]]
+* [[Abdominal distention]]
-* [[Tachycardia]]
-* [[Nausea and vomiting]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* [[Hydrogen breath test]]
+* Lactose tolerance test
+* Genetic testing
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* [[Bloating]]
+* [[Headache]]
-* [[Flatulence]]
+* [[Vertigo]]
-* Symptoms begin mainly after ingestion of [[lactose]]
+* [[Memory impairment]]
+* [[Lethargy]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Reduction of lactase enzyme activity or inability to produce persistent [[lactase]]
 * Congenital [[lactase deficiency]]
+* Secondary lactose malabsorption
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* [[Lactase]] activity assay
+* [[Small bowel]] [[biopsy]]
+* Lactose breath hydrogen test
 |-
 ! colspan="2" style="background:#DCDCDC;" align="center" |[[Irritable bowel syndrome]]
@@ Line 450: / Line 469: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[Abdominal tenderness]]
-* [[Flatulence]]
+* [[Abdominal distention]]
 * Normal [[Stomach rumble|bowel sounds]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
+*[[Anxiety]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+*[[Palpitation]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
+*Unknown
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Diagnosis of exclusion
@@ Line 487: / Line 505: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Positive [[fecal fat]]
@@ Line 522: / Line 540: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* [[Pallor]]
 * Angular [[stomatitis]]
-* [[Oral ulcer|Mouth ulcers]]
+* Oral mucosal lesion
-* [[Edema]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[Fat soluble vitamins]] deficiency
@@ Line 543: / Line 559: @@
 *[[Myalgia]]
 *[[Neuropathy]]
+*[[Edema]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * ''[[Escherichia coli]]''
@@ Line 560: / Line 577: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* [[Muscle atrophy]]
 * [[Abdominal distension|Abdominal distention]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 *Positive [[fecal fat]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[Hypoalbuminemia]]
@@ Line 598: / Line 614: @@
 * [[Abdominal distention]]
 * [[Rebound tenderness|Rebound abdominal tenderness]]
-* [[Lethargy]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* [[ELISA|enzyme–linked immunoabsorbant assay]] (ELISA)
+* [[Enzyme linked immunosorbent assay (ELISA)|Enzyme–linked immunosorbent assay]] ([[Enzyme linked immunosorbent assay (ELISA)|ELISA]])
 * [[Polymerase chain reaction]] ([[Polymerase chain reaction|PCR]]) assay or ''[[Clostridium difficile infection|C. difficile]]'' antigen
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
@@ Line 638: / Line 653: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*[[Dehydration]]
 *Diffuse [[abdominal tenderness]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Nl
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Toxic megacolon]]
@@ Line 672: / Line 685: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*[[Hypotension]]
-*[[Tachycardia]]
 *[[Abdominal distention]]
 *Diffuse [[abdominal tenderness]]
@@ Line 680: / Line 691: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 *Positive serologic testing
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
@@ Line 723: / Line 734: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
@@ Line 759: / Line 770: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*[[Dehydration]]
 *Diffuse [[abdominal tenderness]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Escherichia coli|''Enterotoxigenic escherichia coli'']]
@@ Line 792: / Line 800: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*[[Dehydration]]
 *Diffuse [[abdominal tenderness]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *''[[Enteropathogenic E. coli]]''
@@ Line 823: / Line 828: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*[[Dehydration]]
 *Diffuse [[abdominal tenderness]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Escherichia coli enteritis|''Enteroinvasive E. coli'']]
@@ Line 854: / Line 856: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*[[Dehydration]]
 *Diffuse [[abdominal tenderness]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
@@ Line 886: / Line 887: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*[[Dehydration]]
 *Diffuse [[abdominal tenderness]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
@@ Line 897: / Line 897: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Chronic infection in [[Immunodeficiency|immunocompromised]] patients
@@ Line 922: / Line 921: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Bacteremia]]
@@ Line 938: / Line 936: @@
 *[[Abscess]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Yersinia enterocolitica]]
+*[[Yersinia enterocolitica|''Yersinia enterocolitica'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Stool culture]]
@@ Line 952: / Line 950: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*Severe [[dehydration]]
-*[[Hypotension]]
-*Tachycardia
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Azotemia]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+*Severe [[dehydration]]
 *Decreased [[Turgor|skin turgor]]
 *[[Oliguria]]
@@ Line 994: / Line 990: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Wound [[infection]]
@@ Line 1,015: / Line 1,010: @@
 *[[Opportunistic infection|Opportunistic infections]] in [[Immunodeficiency|immunocompromised]] patients
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*Aeromonas virulence factors including [[Endotoxin|endotoxins]], [[Hemolysin|hemolysins]], [[Enterotoxin|enterotoxins]], and adherence factors
+*''[[Aeromonas]]'' virulence factors including [[Endotoxin|endotoxins]], [[Hemolysin|hemolysins]], [[Enterotoxin|enterotoxins]], and adherence factors
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Blood culture]]
@@ Line 1,035: / Line 1,030: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Opportunistic infection|Opportunistic infections]] in [[Immunodeficiency|immunocompromised]] patients or [[Hepato-biliary diseases|hepatobiliary disease]]
@@ Line 1,054: / Line 1,048: @@
 *Septic [[Pregnancy termination complications|abortion]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Plesiomonas shigelloides]]
+*[[Plesiomonas shigelloides|''Plesiomonas shigelloides'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Blood culture]]
@@ Line 1,073: / Line 1,067: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated [[Liver function tests|liver enzymes]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+*[[Opportunistic infection]] in [[Immunodeficiency|immunocompromised]] patients
 *[[Pulmonary]] [[infection]]
 *[[Lymphadenopathy|Adenopathy]]
 *[[Sleep hyperhidrosis|Night sweats]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Mycobacterium avium complex]]
+*[[Mycobacterium avium complex|''Mycobacterium avium complex'']]
-*[[Opportunistic infection]] in [[Immunodeficiency|immunocompromised]] patients
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Blood culture]]
@@ Line 1,108: / Line 1,101: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |±
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[stool culture]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *History of travel or ingestion of infected food
@@ Line 1,138: / Line 1,130: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive stool reverse–transcriptase [[polymerase chain reaction]] (RT–PCR)
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Myalgia]]
@@ Line 1,152: / Line 1,143: @@
 *[[Encephalopathy]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Norovirus]]
+*[[Norovirus|''Norovirus'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Clinical diagnosis
@@ Line 1,165: / Line 1,156: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="Left" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
+* Hyperactive [[Stomach rumble|bowel sounds]]
+* Diffuse [[abdominal tenderness]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated [[blood urea nitrogen]]
@@ Line 1,185: / Line 1,177: @@
 *[[Central nervous system]] involvement
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*Rotavirus
+*[[Rotavirus|''Rotavirus'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Stool immune–based assays
@@ Line 1,199: / Line 1,191: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*
+*[[Abdominal distension|Abdominal distention]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Hepatic failure|Liver failure]]
 *[[Myocarditis]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Echovirus]]
+*[[Echovirus|''Echovirus'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Clinical diagnosis
@@ Line 1,229: / Line 1,219: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-*
+*[[Abdominal distension|Abdominal distention]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Viral antigen assay
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Respiratory disease]]
@@ Line 1,251: / Line 1,240: @@
 *[[Bacteremia]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Adenoviridae|Adenovirus]]
+*[[Adenoviridae|''Adenovirus'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Clinical diagnosis
@@ Line 1,269: / Line 1,258: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Viral antigen assay
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Decreased [[CD4]] level
@@ Line 1,287: / Line 1,276: @@
 *[[Venous thromboembolism|Venous thrombosis]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Cytomegalovirus]]
+*[[Cytomegalovirus|''Cytomegalovirus'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Quantitative polymerase chain reaction|Quantitative PCR]] tests
@@ Line 1,306: / Line 1,295: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Decreased [[CD4]] level
@@ Line 1,319: / Line 1,307: @@
 *Disseminated [[infection]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Human Immunodeficiency Virus (HIV)|HIV]]
+*[[Human Immunodeficiency Virus (HIV)|''HIV'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *HIV virologic (viral load) test
@@ Line 1,340: / Line 1,328: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Liver abscess]]
@@ Line 1,375: / Line 1,361: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
@@ Line 1,406: / Line 1,391: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive stool microscopy
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated [[alkaline phosphatase]]
@@ Line 1,436: / Line 1,421: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive stool microscopy
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Decreased [[CD4]] count
@@ Line 1,469: / Line 1,454: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive stool microscopy
 *Positive [[fecal fat]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated [[Eosinophil granulocyte|eosinophils]]
@@ Line 1,483: / Line 1,468: @@
 *Chronic illness in [[Immunodeficiency|immunocompromised]] patients
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*[[Isospora]]
+*[[Isospora|''Isospora'']]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Detecting oocysts in the feces
@@ Line 1,499: / Line 1,484: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
 * [[Abdominal distention]]
-* [[Tachycardia]]
-* [[Hypertension]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated urinary [[5-Hydroxyindoleacetic acid|5–hydroxyindoleacetic acid]] ([[5-Hydroxyindoleacetic acid|5–HIAA]]) level
@@ Line 1,535: / Line 1,516: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
-* [[Tachycardia]]
+* [[Abdominal distention]]
-* [[Abdominal distention]]
 * Abdominal [[RUQ]] [[tenderness]]
 * [[Nausea]]
@@ Line 1,544: / Line 1,524: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated [[VIP]] level
@@ Line 1,581: / Line 1,560: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Positive [[secretin]] stimulation test
@@ Line 1,611: / Line 1,589: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated fasting plasma [[somatostatin]]
@@ Line 1,643: / Line 1,620: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Paraproteinemia]]
@@ Line 1,674: / Line 1,650: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Positive [[carcinoembryonic antigen]]
@@ Line 1,718: / Line 1,693: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑/↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated plasma level of drug
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
+*[[Inflammation]]
+*[[Pseudomembranous enterocolitis|Pseudomembranous colitis]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*Inflammation
+*Clinical evaluation after discontinuation of the drugs
-*Pseudomembranous colitis
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*Clinical evaluation after discontinuation of the drgs
 |-
 ! colspan="2" style="background:#DCDCDC;" align="center" |Factitious diarrhea
@@ Line 1,744: / Line 1,717: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
 *[[Abdominal distention]]
-*[[Dehydration]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↑/↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Hypokalemia]]
@@ Line 1,764: / Line 1,735: @@
 *[[Acute kidney injury|Acute renal failure]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*Medications
+*[[Medication|Medications]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*Clinical evaluation after discontinuation of the drgs
+*Clinical evaluation after discontinuation of the drugs
 |-
 ! colspan="2" style="background:#DCDCDC;" align="center" |[[Heavy metal ingestion]]
@@ Line 1,779: / Line 1,750: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
 *[[Abdominal distention]]
-*[[Dehydration]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Elevated plasma heavy metal level
@@ Line 1,797: / Line 1,766: @@
 *[[Vertigo]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*Heavy metal ingestion
+*[[Heavy metal ingestion]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Plasma level of heavy metal
@@ Line 1,812: / Line 1,781: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
 *[[Saliva|Salivation]]
-*[[Nausea and vomiting|Emesis]]
+*[[Nausea and vomiting|Vomiting]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Reduced RBC acetylcholinesterase
@@ Line 1,853: / Line 1,821: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="Left" |
 *Hyperactive [[Stomach rumble|bowel sounds]]
-*[[Tachycardia]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-*
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Azotemia]]
@@ Line 1,896: / Line 1,862: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[fecal fat]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ↑
@@ Line 1,905: / Line 1,871: @@
 * [[Hypoalbuminemia]]
 * High level of [[Acute phase protein|acute phase reactant]]
-* Abnormal liver function tests
+* Abnormal [[liver function tests]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* Prior intestinal surgery
+* Prior [[Intestine|intestinal]] surgery
 * [[Malabsorption]]
 * [[Crohn's disease]]
@@ Line 1,932: / Line 1,898: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[fecal fat]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Vitamin B12 deficiency
@@ Line 1,964: / Line 1,930: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" |–
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * [[Hypoglycemia]]
@@ Line 1,995: / Line 1,961: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-*
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Low [[triglyceride]]
@@ Line 2,011: / Line 1,976: @@
 * [[Dysarthria]]
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
-* [[Autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP)
+* [[Autosomal recessive]] disorder caused by mutations encoding the [[microsomal triglyceride transfer protein]] (MTP)
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Clinical findings and low [[triglyceride]] and [[cholesterol]] level
@@ Line 2,024: / Line 1,989: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
-| style="padding: 5px 5px; background: #F5F5F5;" align="left" |
+| style="padding: 5px 5px; background: #F5F5F5;" align="left" |–
-* [[Tachycardia]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[fecal fat]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Elevated [[T4]]
@@ Line 2,070: / Line 2,034: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[fecal fat]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *[[Hyperglycemia]]
@@ Line 2,105: / Line 2,069: @@
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 *Positive [[fecal fat]]
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓
-| style="padding: 5px 5px; background: #F5F5F5;" align="center" | –
+| style="padding: 5px 5px; background: #F5F5F5;" align="center" | Nl
 | style="padding: 5px 5px; background: #F5F5F5;" align="left" |
 * Anti–[[Type I topoisomerase|topoisomerase I]] (Scl‑70) antibodies
@@ Line 2,131: / Line 2,095: @@
 |- }
 |}
+<references />

Sandbox: malabsorption: Difference between revisions

Latest revision as of 16:37, 21 December 2017

Differential Diagnosis of Diarrhea

Diarrhea

Navigation menu